USFDA completes inspection at Alkem Laboratories’ manufacturing facility in Daman

31 Aug 2019

The US Food and Drug Administration (USFDA) has completed inspection at Alkem Laboratories’ manufacturing facility located at Daman. The agency had conducted inspection from August 26, 2019 to August 30, 2019. At the end of the inspection, the company has received a Form 483 with two observations.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Related Alkem Laboratories Ltd. Links:

Alkem Laboratories Share Price

3490.25 -86.25 (-2.41%) Jan 18, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 845.90
Cipla 902.25
Dr. Reddy's Lab 4689.50
Aurobindo Pharma 669.30
Lupin 942.55
View more..
Sensex vs Alkem Laboratories